Celik, H., Hong, S.H., Colón-López, D.D., Han, J., Saygideger Kont, Y., Minas, T.Z., Swift, M., Paige, M., Glasgow, E., Toretsky, J.A., Bosch, J., Uren, A. (2015) Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box. Molecular cancer therapeutics. 14(11):2497-507
|
Jin, W., Gu, C., Zhou, L., Yang, X., Gui, M., Zhang, J., Chen, J., Dong, X., Yuan, Q., Shan, L. (2020) Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms. Oncology reports. 44(6):2621-2633
|
Jin, W., Zhou, L., Yan, B., Yan, L., Liu, F., Tong, P., Yu, W., Dong, X., Xie, L., Zhang, J., Xu, Y., Li, C., Yuan, Q., Shan, L., Efferth, T. (2018) Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway. Journal of Cellular and Molecular Medicine. 22(9):4423-4436
|
Liu, J.L., Li, J., Xu, J.J., Xiao, F., Cui, P.L., Qiao, Z.G., Zhang, X.L. (2019) MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via dual-suppressing RhoA/ROCK1 Signaling Pathway. Molecular pharmacology. 95(4):451-461
|
|
|
|
|
Mohseny, A.B., Xiao, W., Carvalho, R., Spaink, H.P., Hogendoorn, P.C., and Cleton-Jansen, AM. (2012) An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration. The Journal of pathology. 227(2):245-253
|
|
|
Yu, S., Guo, L., Yan, B., Yuan, Q., Shan, L., Zhou, L., Efferth, T. (2022) Tanshinol suppresses osteosarcoma by specifically inducing apoptosis of U2-OS cells through p53-mediated mechanism. Journal of ethnopharmacology. 292:115214
|
